Study summary

The purpose of the trial is to assess the immunological effects and their kinetics, the safety and activity of IMAB362 plus Zoledronic acid with/without low to intermediate doses of Interleukin-2 in subjects with advanced gastroesophageal cancer.

Additional Study Details

Phase
1
Product
  • IMAB362
  • Zoledronic acid
  • Interleukin-2 (1 million IU)
  • Interleukin-2 (3 million IU)
  • Type
    Interventional
    Masking
    N/A
    Enrollment number
    29
    Show Additional Study Details

    Study documents

    Scientific Results Summary
    Available Language(s): English
    Plain Language Summary
    Available Language(s): English

    Get more information

    Would you like more information about clinical trial sites that are recruiting participants for Safety and activity of IMAB362 in combination with zoledronic acid and interleukin-2 in CLDN18.2-positive Gastric Cancer? Contact us by filling out your information to the right and we’ll respond to you.

    • A patient
    • A caregiver
    • A parent
    • A healthcare provider
    • A patient advocate
    • Algeria
    • Argentina
    • Armenia
    • Australia
    • Austria
    • Belarus
    • Belgium
    • Bosnia And Herzegovina
    • Brazil
    • Bulgaria
    • Canada
    • Chile
    • China
    • Colombia
    • Croatia
    • Czech Republic
    • Denmark
    • Dominican Republic
    • Egypt
    • Estonia
    • Finland
    • Former Serbia and Montenegro
    • France
    • Georgia
    • Germany
    • Greece
    • Guatemala
    • Hong Kong
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Ireland
    • Israel
    • Italy
    • Japan
    • Jordan
    • Kazakhstan
    • Latvia
    • Lebanon
    • Lithuania
    • Macedonia
    • Malaysia
    • Mexico
    • Montenegro
    • Morocco
    • Netherlands
    • New Zealand
    • Norway
    • Panama
    • Peru
    • Philippines
    • Poland
    • Portugal
    • Puerto Rico
    • Republic of Korea
    • Republic of Moldova
    • Romania
    • Russian Federation
    • Saudi Arabia
    • Serbia
    • Singapore
    • Slovakia
    • Slovenia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Taiwan, Province of China
    • Thailand
    • Turkey
    • Ukraine
    • United Kingdom
    • United States
    • Vietnam

    By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

      Locations

      Contact Us
      Contact Us
      Recruiting
      Freiburg University Medical Center, Department of Internal Medicine II, Gastroenterology and Hepatology
      Freiburg, Germany, 79106
      Recruiting
      University Hospital Tuebingen, Department of Internal Medicine I - Gastroenterology, Hepatology, Infectious Diseases
      Tübingen, Germany, 72076
      Recruiting
      Piejuras Hospital, Oncology Clinic
      Liepaja, Latvia, 3401
      Withdrawn
      Military Medical Academy - Multiprofile Hospital for Active Treatment, Sofia, Department of Medical Oncology
      Sofia, Bulgaria, 1606
      Active, not recruiting
      Institut für Klinische Forschung, Krankenhaus Nordwest GmbH
      Frankfurt, Hessen, Germany, 60488
      Withdrawn
      University Hospital Halle (Saale), Department of Internal Medicine IV
      Halle, Germany, 06120
      Recruiting
      BAG / Onkologische Schwerpunktpraxis
      Dresden, Sachsen, Germany, 01307
      Recruiting
      Riga East University Hospital, LLC, Latvian Oncology Center
      Riga, Latvia, LV1038
      Withdrawn
      Hospital Znojmo, Department of Radiation and Clinical Oncology
      Znojmo, Czech Republic, 66902
      Withdrawn
      Multiprofile Hospital for Active Treatment "Sveta Marina", Varna, Clinic of Medical Oncology
      Varna, Bulgaria, 9010
      Recruiting
      Leipzig University Hospital, University Cancer Center (UCCL)
      Leipzig, Germany, 04109
      Withdrawn
      University Multiprofile Hospital for Active Treatment "Tsaritsa Yoanna - ISUL", Sofia, Clinic of Medical Oncology
      Sofia, Bulgaria, 1527
      Recruiting
      Ulm University Hospital, Center for Internal Medicine
      Ulm, Germany, 89070
      Recruiting
      Charité Universitätsmedizin Berlin - CVK, Med. Klinik m.S. Hämatologie und Onkologie
      Berlin, Berlin, Germany, 13353
      Withdrawn
      University Hospital Motol, Department of Radiotherapy and Oncology
      Prague, Czech Republic, 15006

      Frequently Asked Questions

      Are clinical trials only for people with advanced cancer?

      While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

      Will I have to stop my current treatment to participate in a clinical trial?

      Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

      Should I be worried about getting a placebo?

      In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

      Do I need a referral from my doctor to take part in a study?

      Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

      Explore More

      1

      What are clinical trials?

      2

      Why are Clinical Trials Important?

      3

      Why Participate in a Clinical Trial?